WSJ: IMS eyes IPO at valuation of $7B

IMS Health Holdings' (IMS) owners hope to raise $1B in an IPO that would value the company at $7B, the WSJ reports.

IMS, which provides data on prescriptions, medical claims and sales to healthcare companies, could price its shares at $21 each and carry out the listing within two weeks.

The IPO looks like it should represent a decent return for investors TPG, Leonard Green and the Canada Pension Plan Investment Board: IMS was taken private in 2010 for $4B. Since then, it has paid $2B in dividends using borrowed money. IMS will use proceeds from the IPO to repay debt.


From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs